Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer.
伊伐布雷定可诱导 RAD51 降解，增强 PARP 抑制剂在非种系 BRCA 致病变异三阴性乳腺癌中的疗效
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06902-8
Tsoi Ho, Leung George Man Hong, Man Ellen Pui Sum, You Chan Ping, Cheung Koei Ho Lam, Chan Kelvin Yuen Kwong, Gong Chun, Huen Michael Shing Yan, Khoo Ui Soon
